1 The Department of Pediatrics, University of Southern California, School of Medicine, Los Angeles, California
The newborn infants of 56 mothers who used cocaine were prospectively studied in to determine the effects of cocaine. There were no differences with respect to maternal preeclampsia or cesarean section rate. Meconium-stained amniotic fluid was increased (10 of 56 cases [17.8%]) compared with the control group (3 of 56 cases [5.3%]) (x2 = 4.2, P < .05). Fetal distress recorded with fetal monitoring and Apgar scores at 1 and 5 minutes were similar. The weight, length, and head circumference growth curves of the infants born to cocaine-using mothers were shifted below the 25th percentile. Microcephaly was present in 12 of 56 (21.4%) infants whose mothers used cocaine during pregnancy (x2 = 5.96, P < .01), and 15 of 56 (26.7%) had intrauterine growth retardation (x2 = 9.53, P < .01) compared with the control infants (2 of 5 [3.5%] and 3 of 56 [5.3%], respectively). There was no increase in teratogenicity. Neither narcotic withdrawal symptoms nor illness could distinguish the infants born of cocaine-using mothers from the control infants. In conclusion, cocaine use during pregnancy results in newborn infants with growth retardation and microcephaly.
Key Words: cocaine intrauterine growth retardation pregnancy microcephaly
Submitted on November 14, 1988
Accepted on January 17, 1989
This article has been cited by other articles:
![]() |
L. M. Smith, L. L. LaGasse, C. Derauf, P. Grant, R. Shah, A. Arria, M. Huestis, W. Haning, A. Strauss, S. D. Grotta, et al. The Infant Development, Environment, and Lifestyle Study: Effects of Prenatal Methamphetamine Exposure, Polydrug Exposure, and Poverty on Intrauterine Growth Pediatrics, September 1, 2006; 118(3): 1149 - 1156. [Abstract] [Full Text] [PDF] |
||||
![]() |
L L LaGasse, D Messinger, B M Lester, R Seifer, E Z Tronick, C R Bauer, S Shankaran, H S Bada, L L Wright, V L Smeriglio, et al. Prenatal drug exposure and maternal and infant feeding behaviour Arch. Dis. Child. Fetal Neonatal Ed., September 1, 2003; 88(5): F391 - F399. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Bada, A. Das, C. R. Bauer, S. Shankaran, B. Lester, L. L. Wright, J. Verter, V. L. Smeriglio, L. P. Finnegan, and P. L. Maza Gestational Cocaine Exposure and Intrauterine Growth: Maternal Lifestyle Study Obstet. Gynecol., November 1, 2002; 100(5): 916 - 924. [Abstract] [Full Text] [PDF] |
||||
![]() |
H S Bada, C R Bauer, S Shankaran, B Lester, L L Wright, A Das, K Poole, V L Smeriglio, L P Finnegan, and P L Maza Central and autonomic system signs with in utero drug exposure Arch. Dis. Child. Fetal Neonatal Ed., September 1, 2002; 87(2): F106 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
Policy Statements Adopted by the Governing Council of the American Public Health Association, October 24, 2001 Am J Public Health, March 1, 2002; 92(3): 451 - 483. [Full Text] [PDF] |
||||
![]() |
M. Behnke, F. D. Eyler, C. W. Garvan, and K. Wobie The Search for Congenital Malformations in Newborns With Fetal Cocaine Exposure Pediatrics, May 1, 2001; 107(5): 74e - 74. [Abstract] [Full Text] |
||||
![]() |
H. J. Kliman Uteroplacental Blood Flow : The Story of Decidualization, Menstruation, and Trophoblast Invasion Am. J. Pathol., December 1, 2000; 157(6): 1759 - 1768. [Full Text] [PDF] |
||||
![]() |
I. H. Gewolb, J. O'Brien, and R. E. Slavin Opioids Accelerate Fetal Rat Lung Maturation In Vitro Am. J. Respir. Cell Mol. Biol., March 1, 1999; 20(3): 511 - 516. [Abstract] [Full Text] |
||||
![]() |
R. Arendt, J. Angelopoulos, A. Salvator, and L. Singer Motor Development of Cocaine-exposed Children at Age Two Years Pediatrics, January 1, 1999; 103(1): 86 - 92. [Abstract] [Full Text] [PDF] |
||||
![]() |
Committee on Drugs Neonatal Drug Withdrawal. Pediatrics, June 1, 1998; 101(6): 1079 - 1079. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. D. Eyler, M. Behnke, M. Conlon, N. S. Woods, and K. Wobie Birth Outcome From a Prospective, Matched Study of Prenatal Crack/Cocaine Use: I. Interactive and Dose Effects on Health and Growth Pediatrics, February 1, 1998; 101(2): 229 - 236. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. MacMahon Perinatal Substance Abuse: The Impact of Reporting Infants to Child Protective Services Pediatrics, November 1, 1997; 100(5): e1 - e1. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Beltran, T. Bell, S. Fisher, and S. Ros Utility of Laboratory Screening in Cocaine-Exposed Infants Clinical Pediatrics, November 1, 1994; 33(11): 683 - 685. [PDF] |
||||
![]() |
C. Carraccio, J. Papadimitriou, and P. Feinberg Subcutaneous Fat Necrosis of the Newborn: Link to Maternal Use of Cocaine During Pregnancy Clinical Pediatrics, May 1, 1994; 33(5): 317 - 318. [Abstract] [PDF] |
||||
![]() |
L. C. MAYES Prenatal Cocaine Exposure and Young Children's Development The ANNALS of the American Academy of Political and Social Science, May 1, 1992; 521(1): 11 - 27. [Abstract] |
||||
![]() |
K. Rais-Bahrami and M. Naqvi Hydraneno aly and Maternal Cocaine Use: A Case Report Clinical Pediatrics, December 1, 1990; 29(12): 729 - 730. [PDF] |
||||
![]() |
EFFECT OF COCAINE ON THE FETUS Journal Watch (General), August 15, 1989; 1989(815): 2 - 2. [Full Text] |
||||